🇺🇸 WellbutrinXL in United States

13 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 13

Most-reported reactions

1. Depression — 2 reports (15.38%)
2. Drug Ineffective — 2 reports (15.38%)
3. Product Substitution Issue — 2 reports (15.38%)
4. Agitation — 1 report (7.69%)
5. Anxiety — 1 report (7.69%)
6. Condition Aggravated — 1 report (7.69%)
7. Crying — 1 report (7.69%)
8. Death — 1 report (7.69%)
9. Malaise — 1 report (7.69%)
10. Product Complaint — 1 report (7.69%)

Source database →

Frequently asked questions

Is WellbutrinXL approved in United States?

WellbutrinXL does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for WellbutrinXL in United States?

GlaxoSmithKline is the originator. The local marketing authorisation holder may differ — check the official source linked above.